Neurochemical Research

, Volume 40, Issue 4, pp 767–776 | Cite as

Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer’s Disease in Wistar Rats

  • Arokiasamy Justin Thenmozhi
  • Tharsius Raja William Raja
  • Udaiyappan Janakiraman
  • Thamilarasan Manivasagam
Original Paper


The present study was aimed to evaluate the protective effect of hesperidin (Hes) on aluminium chloride (AlCl3) induced neurobehavioral and pathological changes in Alzheimeric rats. Intraperitonial injection of AlCl3 (100 mg/kg body weight) for 60 days significantly elevated the levels of aluminium (Al), activity of acetylcholinesterase (AChE) and protein expressions of amyloid precursor protein (APP), β amyloid (Aβ1–42), β and γ secretases as compared to control group in hippocampus and cortex of rat brain. Hes administration orally along with AlCl3 injection for 60 days, significantly revert the Al concentration, AChE activity and Aβ synthesis-related molecules in the studied brain regions. Our results showed that aluminum exposure was significantly reduced the spontaneous locomotor and exploratory activities in open field test and enhanced the learning and memory impairments in morris water maze test. The behavioral impairments caused by aluminum were significantly attenuated by Hes. The histopathological studies in the hippocampus and cortex of rat brain also supported that Hes (100 mg/kg) markedly reduced the toxicity of AlCl3 and preserved the normal histoarchitecture pattern of the hippocampus and cortex. From these results, it is concluded that hesperidin can reverse memory loss caused by aluminum intoxication through attenuating AChE activity and amyloidogenic pathway.


Alzheimer’s disease AlCl3 Hesperidin Memory loss Aβ synthesis 



Financial assistance in the form of a major research project from the Department of Science and Technology, New Delhi, is gratefully acknowledged.

Conflict of interest

Hereby, the authors declare that they have no conflict of interest that might have influenced the views expressed in this manuscript.


  1. 1.
    Cam JA, Bu GJ (2006) Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family. Mol Neurodegener 8:1–13Google Scholar
  2. 2.
    Ribes D, Colomina MT, Vicens P, Domingo JL (2008) Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer’s disease. Exp Neurol 214:293–300CrossRefPubMedGoogle Scholar
  3. 3.
    Akila R, Stollery BT, Riihimaki V (1999) Decrements in cognitive performance in metal inert gas welders exposed to aluminium. Occup Environ Med 56:632–639PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Drago D, Folin M, Baiguera S, Tognon G, Ricchelli F, Zatta P (2007) Comparative effects of Abeta(1–42)-Al complex from rat and human amyloid on rat endothelial cell cultures. J Alzheimers Dis 11:33–44PubMedGoogle Scholar
  5. 5.
    Zaky A, Mohammad B, Moftah M, Kandeel KM, Bassiouny AR (2013) Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation. BMC Neurosci 14:26PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Gulya K, Rakonczay Z, Kasa P (1990) Cholinotoxic effects of aluminium in rat brain. J Neurochem 54:1020–1026CrossRefPubMedGoogle Scholar
  7. 7.
    Rakonczay Z, Horváth Z, Juhász A, Kálmán J (2005) Peripheral cholinergic disturbances in Alzheimer’s disease. Chem Biol Interact 157–158:233–238CrossRefPubMedGoogle Scholar
  8. 8.
    Standridge JB (2004) Pharmacotherapeutic approaches to the prevention of Alzheimer’s disease. Am J Geriatr Pharmacother 2:119–132CrossRefPubMedGoogle Scholar
  9. 9.
    Espín JC, García-Conesa MT, Tomás-Barberán FA (2007) Nutraceuticals: facts and fiction. Phytochemistry 68:2986–3008CrossRefPubMedGoogle Scholar
  10. 10.
    Spencer JP (2007) The interactions of flavonoids within neuronal signalling pathways. Genes Nutr 2:257–273PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, Bickford PC (1999) Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19:8114–8121PubMedGoogle Scholar
  12. 12.
    Gaur V, Aggarwal A, Kumar A (2011) Possible nitric oxide mechanism in the protective effect of hesperidin against ischemic reperfusion cerebral injury in rats. Indian J Exp Biol 49:609–618PubMedGoogle Scholar
  13. 13.
    Salem HRA, El-Raouf AA, Saleh EM, Shalaby KAF (2012) Influence of hesperidin combined with Sinemet on genetical and biochemical abnormalities in rats suffering from Parkinson’s disease. Life Sci J 9:930–945Google Scholar
  14. 14.
    Dimpfel W (2006) Different anticonvulsive effects of hesperidin and its aglycone hesperetin on electrical activity in the rat hippocampus in-vitro. J Pharm Pharmacol 58:375–379CrossRefPubMedGoogle Scholar
  15. 15.
    Kumar P, Kumar A (2010) Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington’s like symptoms in rats: possible role of nitric oxide. Behav Brain Res 206:38–46CrossRefPubMedGoogle Scholar
  16. 16.
    Raza SS, Khan MM, Ahmad A, Ashafaq M, Khuwaja G, Tabassum R, Javed H, Siddiqui MS, Safhi MM, Islam F (2011) Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke. Brain Res 1420:93–105CrossRefPubMedGoogle Scholar
  17. 17.
    Ikemura M, Sasaki Y, Giddings JC, Yamamoto J (2012) Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats. Phytother Res 26:1272–1277CrossRefPubMedGoogle Scholar
  18. 18.
    Viswanatha GL, Shylaja H, Sandeep Rao KS, Santhosh Kumar VR, Jagadeesh M (2012) Hesperidin ameliorates immobilization-stress-induced behavioral and biochemical alterations and mitochondrial dysfunction in mice by modulating nitrergic pathway. ISRN Pharmacol 479–570Google Scholar
  19. 19.
    Abdel-Aal RA, Assi AA, Kostandy BB (2011) Rivastigmine reverses aluminum-induced behavioral changes in rats. Eur J Pharmacol 659:169–176CrossRefPubMedGoogle Scholar
  20. 20.
    Fernagut PO, Diguet E, Stefanova N, Biran M, Wenning GK, Canioni P, Bioulac B, Tison F (2002) Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience 114:1005–1017CrossRefPubMedGoogle Scholar
  21. 21.
    Sethi P, Jyoti A, Singh R, Hussain E, Sharma D (2008) Aluminium-induced electrophysiological, biochemical and cognitive modifications in the hippocampus of aging rats. Neurotoxicology 29:1069–1079CrossRefPubMedGoogle Scholar
  22. 22.
    Morris R (1984) Developments of a water maze procedure for studing spatial learning in the rat. J Neurosci Methods 11:47–60CrossRefPubMedGoogle Scholar
  23. 23.
    RajaSankar S, Manivasagam T, Surendran S (2009) Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson’s disease. Neurosci Lett 454:11–15CrossRefPubMedGoogle Scholar
  24. 24.
    Erazi H, Sansar W, Ahboucha S, Gamrani H (2010) Aluminum affects glial system and behavior of rats. C R Biol 333:23–27CrossRefPubMedGoogle Scholar
  25. 25.
    Hartmann M, Heumann R, Lessmann V (2001) Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J 20:5887–5897PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  27. 27.
    Annida B, Menon VP (2007) Protective effect of hesperidin on nicotine induced toxicity in rats. Indian J Exp Biol 45:194–202Google Scholar
  28. 28.
    Sakamoto T, Ogasawara Y, Ishii K, Takahashi H, Tanabe S (2004) Accumulation of aluminum in ferritin isolated from rat brain. Neurosci Lett 366:264–267CrossRefPubMedGoogle Scholar
  29. 29.
    Abubakar MG, Taylor A, Ferns GAA (2004) Regional accumulation of aluminium in the rat brain is affected by dietary vitamin E. J Trace Elem Med Biol 18:53–59CrossRefPubMedGoogle Scholar
  30. 30.
    Roskams AJ, Connor JR (1990) Aluminum access to the brain: a role for transferrin and its receptors. Proc Natl Acad Sci USA 87:9024–9027PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Kaur A, Gill KD (2006) Possible peripheral markers for chronic aluminium toxicity in Wistar rats. Toxicol Ind Health 22:39–46CrossRefPubMedGoogle Scholar
  32. 32.
    Crapper DR, Krishnan SS, Dalton AJ (1973) Brain aluminum distribution in Alzheimer’s disease and experimental neurofibrillary degeneration. Science 180:511–513CrossRefPubMedGoogle Scholar
  33. 33.
    Pavun LA, Dimitricmarkovic JM, Durdevic PT, Jelikic-Stankov MD, Dikanovic DB, Ciric AR, Malesev DL (2012) Development and validation of a fluorometric method for the determination of hesperidin in human plasma and pharmaceutical forms. J Serb Chem Soc 77:1625–1640CrossRefGoogle Scholar
  34. 34.
    Shagirtha K, Pari L (2011) Hesperetin, a citrus flavonone, protects potentially cadmium induced oxidative testicular dysfunction in rats. Ecotoxicol Environ Saf 74:2105–2111CrossRefPubMedGoogle Scholar
  35. 35.
    Kuntic V, Filipovic I, Vujic Z (2011) Effects of rutin and hesperidin and their Al(III) and Cu(II) complexes on in vitro plasma coagulation assays. Molecules 16:1378–1388CrossRefPubMedGoogle Scholar
  36. 36.
    Amberla K, Nordberg A, Viitanen M, Winblad B (2009) Long-term treatment with tacrine (THA) in Alzheimers disease evaluation of neuropsychological data. Acta Neurol Scand Suppl 149:55–57CrossRefGoogle Scholar
  37. 37.
    Zheng H, Youdim MB, Fridkin M (2009) Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer’s therapy. J Med Chem 52:4095–4098CrossRefPubMedGoogle Scholar
  38. 38.
    Zatta P, Zambenedetti P, Bruna V, Filippi B (1994) Activation of acetylcholinesterase by aluminium(III): the relevance of the metal species. NeuroReport 5:1777–1780CrossRefPubMedGoogle Scholar
  39. 39.
    Kakkar V, Kaur IP (2011) Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol 49:2906–2913CrossRefPubMedGoogle Scholar
  40. 40.
    Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer’s disease. Lancet 368:387–403CrossRefPubMedGoogle Scholar
  41. 41.
    Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J (2004) Cholinesterase inhibitors used in the treatment of Alzheimer’s disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 21:453–478CrossRefPubMedGoogle Scholar
  42. 42.
    Javed H, Vaibhav K, Ahmed ME, Khan A, Tabassum R, Islam F, Safhi MM, Islam F (2014) Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice. J Neurol Sci (in press)Google Scholar
  43. 43.
    Young-Pearse TL, Chen AC, Chang R, Marquez C, Selkoe DJ (2008) Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1. Neural Dev 3:15PubMedCentralCrossRefPubMedGoogle Scholar
  44. 44.
    Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca G, Danni O, Zhu XW, Smith MA, Perry G, Jo DG, Mattson MP, Tabaton M (2008) Oxidative stress activates a positive feedback between the γ- and β-secretase cleavages of the β-amyloid precursor protein. J Neurochem 104:683–695PubMedCentralPubMedGoogle Scholar
  45. 45.
    Lin R, Chen X, Li W (2008) Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin. Neurosci Lett 440:344–347CrossRefPubMedGoogle Scholar
  46. 46.
    Luo HB, Yang JS, Shi XQ (2009) Tetrahydroxy stilbene glucoside reduces the cognitive impairment and overexpression of amyloid precursor protein induced by aluminum exposure. Neurosci Bull. 25:391–396CrossRefPubMedGoogle Scholar
  47. 47.
    Lukiw WJ, Percy ME, Kruck TP (2005) Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J Inorg Biochem 99:1895–1898CrossRefPubMedGoogle Scholar
  48. 48.
    Alexandrov PN, Zhao Y, Pogue AI, Tarr MA, Kruck TP, Percy ME, Cui JG, Lukiw WJ (2005) Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells. J Alzheimer’s Dis 8:117–127Google Scholar
  49. 49.
    Ghorbani A, Nazari M, Jeddi-Tehrani M, Zand H (2012) The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ-dependent mechanism. Eur J Nutr 51:39–46CrossRefPubMedGoogle Scholar
  50. 50.
    Nazari M, Ghorbani A, Hekmat-Doost A, Jeddi-Tehrani M, Zand H (2011) Inactivation of nuclear factor-κB by citrus flavanone hesperidin contributes to apoptosis and chemo-sensitizing effect in Ramos cells. Eur J Pharmacol 650:526–533CrossRefPubMedGoogle Scholar
  51. 51.
    Kim JY, Jung KJ, Choi JS, Chung HY (2006) Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell 5:401–411CrossRefPubMedGoogle Scholar
  52. 52.
    Cochran M, Elliott DC, Brennan P, Chawtur V (1990) Inhibition of protein kinase C activation by low concentrations of aluminium. Clin Chim Acta 194:167–172CrossRefPubMedGoogle Scholar
  53. 53.
    Caporaso GL, Gandy SE, Buxbaum JD, Ramabhadran TV, Greengard P (1992) Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89:3055–3059PubMedCentralCrossRefPubMedGoogle Scholar
  54. 54.
    Kawahara M, Kato M, Kuroda Y (2001) Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res Bull 55:211–217CrossRefPubMedGoogle Scholar
  55. 55.
    Li C, Zug C, Qu H, Schluesener H, Zhang Z (2016) Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice. Behav Brain Res 281:32–42CrossRefGoogle Scholar
  56. 56.
    Bastianetto S, Brouillette J, Quirion R (2007) Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin. Neurochem Res 32:1720–1725CrossRefPubMedGoogle Scholar
  57. 57.
    Levites Y, Amit T, Youdim MB, Mandel S (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (−)-epigallocatechin-3-gallate neuronprotective action. J Biol Chem 277:30574–30580CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Arokiasamy Justin Thenmozhi
    • 1
  • Tharsius Raja William Raja
    • 1
  • Udaiyappan Janakiraman
    • 1
  • Thamilarasan Manivasagam
    • 1
  1. 1.Department of Biochemistry and BiotechnologyAnnamalai UniversityAnnamalai NagarIndia

Personalised recommendations